<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="33267">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02673580</url>
  </required_header>
  <id_info>
    <org_study_id>TELEPRO</org_study_id>
    <nct_id>NCT02673580</nct_id>
  </id_info>
  <brief_title>Tele-patient-reported Outcomes (telePRO) in Clinical Practice - Effect of Patient-initiated Versus Fixed Interval telePRO Based Outpatient Follow-up</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Aarhus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Central Denmark Region</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>TrygFonden, Denmark</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Aarhus</source>
  <brief_summary>
    <textblock>
      The aim of this study is to compare quality of care and patient experiences in two
      outpatients follow-up activities: 1) Standard telePRO (fixed interval telePRO follow-up) and
      2) Open Access telePRO (patient-initiated telePRO follow-up)
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2016</start_date>
  <primary_completion_date type="Anticipated">August 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of contacts</measure>
    <time_frame>18 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>General health will be assessed by items from the SF-36 questionnaire</measure>
    <time_frame>18 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Well-being wil be assessed by the WHO-5 Well-being Index</measure>
    <time_frame>18 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>18 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Difference number of seizures (start - end)</measure>
    <time_frame>18 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Side effects</measure>
    <time_frame>18 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health literacy will be assessed by The Health Literacy Questionnaire (sub scale 4, 6, and 9)</measure>
    <time_frame>18 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-efficacy will be assessed by The General Self-Efficacy Scale</measure>
    <time_frame>18 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Confidence will be assessed by one item from the Danish Cancer Society PREM (Barometer) Questionnaire</measure>
    <time_frame>18 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Safety will be assessed by one item from the Danish Cancer Society PREM (Barometer) Questionnaire</measure>
    <time_frame>18 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Satisfaction will be assessed by one item from the Danish Cancer Society PREM (Barometer) Questionnaire</measure>
    <time_frame>18 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Epilepsy</condition>
  <arm_group>
    <arm_group_label>Open Access telePRO</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Patient-initiated telePRO follow-up</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard telePRO</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Fixed interval telePRO follow-up</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Open Access follow-up</intervention_name>
    <description>In open access, contacts to the outpatient clinic are initiated solely by the patient. Contacts may be in the form of a PRO assessment like in standard telePRO, but at a time decided by the patient via the Danish National Health website &quot;Sundhed.dk&quot;.</description>
    <arm_group_label>Open Access telePRO</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Standard follow-up</intervention_name>
    <description>Standard care: fixed interval telePRO follow-up. Patients receive a questionnaire with individually pre-specified intervals.</description>
    <arm_group_label>Standard telePRO</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Males and females from Age 15 years

          -  Diagnosis of epilepsy

          -  Referred to standard telePRO by a clinician

          -  Access to internet (web-responders in standard telePRO)

          -  Can speak and understand Danish

        Exclusion Criteria:

          -  Paper responders

          -  Referred to telePRO proxy questionnaire
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Liv Marit Valen Schougaard, PhD student</last_name>
    <email>livschou@rm.dk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Niels Henrik Hjollund, Professor</last_name>
    <email>niehjo@rm.dk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Regional Hospital West Jutland</name>
      <address>
        <city>Herning</city>
        <state>Central Denmark Region</state>
        <zip>7400</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Liv Marit Valen Schougaard, PhD student</last_name>
      <email>livschou@rm.dk</email>
    </contact>
    <contact_backup>
      <last_name>Niels Henrik Hjollund, Professor</last_name>
      <email>niehjo@rm.dk</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>January 2016</verification_date>
  <lastchanged_date>February 1, 2016</lastchanged_date>
  <firstreceived_date>January 28, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
